时间标签：数据日期 2026-10-31 · 生成时间 2026-11-01 05:30（Asia/Shanghai）｜ 检索窗口 PubMed edat 2026/10/28–2026/10/31 ｜ 情报发生日期 2026-10-31
证据级别：摘要级。本条依据 PubMed 结构化摘要与元数据撰写，付费墙全文未获取、未逐节核验，本站未做任何数值推算补全。
研究问题
Endometrial carcinoma (EC), one of the most common malignancies of the female reproductive tract, predominantly affects postmenopausal women. The incidence of EC has been rising over the past few decades, partly due to increasing rates of obesity, diabetes, and an aging population. A variety of diagnostic techniques exist to assess and diagnose endometrial carcinoma, including histopathology and imaging modalities such as ultrasonography, computed tomography (CT), and magnetic resonance imaging (MRI). MRI can provide valuable information about the anatomical characteristics of the tumor, such as the depth of myometrial invasion, cervical involvement, and the presence of lymph node or distant metastases, which can help guide treatment decisions.
局限
未能获取全文，具体设计细节、失访与统计学处理无法核验。
对本项目的价值
★☆☆☆☆ 相关范围内，作为背景与横向对照收录。
原文题录
- 英文标题：From imaging to insight: Assessing the diagnostic performance of MRI in endometrial cancer staging.
- 期刊与标识：J Cancer Res Ther · PMID 42955981 · DOI 10.4103/jcrt.jcrt_1924_25
B 级证据分级：B 级（同行评议临床前研究，主要为动物模型）
本文核心结论来自动物模型或体外细胞学，属临床前证据，不能外推至人体。「延长健康寿命」「改善功能」等表述在小鼠中的意义，与人类临床结局之间仍有距离。
关于本文的文献来源：本站依据 IMA 知识库「五刊监控·深度文献卡片」（SOP §4.2 摘要级）撰写，依据期刊公开摘要与 PubMed 元数据；付费墙全文未获取之处已标注「待补全文」，未做任何数值推算补全。